EW P/B: current value, 10-year range and year-by-year history
Cash & Leverage
EW's p/b is lower than 83% of the last 10 years.
P/B History
EW P/B by year
Yearly range of EW’s p/b from 2016 to 2026. Over the full period it ranged from 3.9 to 15.1, averaging 8.9.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 4.3 | 4.7 | 5.1 | 4.5 |
| 2025 | 3.9 | 4.4 | 5.0 | 4.8 |
| 2024 | 4.0 | 6.3 | 8.6 | 4.3 |
| 2023 | 5.6 | 7.7 | 9.3 | 6.9 |
| 2022 | 6.9 | 10.3 | 13.9 | 7.5 |
| 2021 | 10.9 | 12.9 | 15.1 | 14.0 |
| 2020 | 8.1 | 11.9 | 14.1 | 12.6 |
| 2019 | 9.7 | 12.1 | 13.7 | 12.0 |
| 2018 | 8.0 | 9.6 | 11.8 | 10.3 |
| 2017 | 6.9 | 8.1 | 9.5 | 7.7 |
| 2016 | 6.6 | 8.3 | 10.7 | 7.6 |
Get notified when EW P/B crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays relative to the company's accounting net worth (assets minus liabilities). P/B < 1 means the market values the company below what the books say it owns.
Price / Book Value Per ShareMost useful for asset-heavy businesses: banks, insurers, REITs. A P/B near its historical low suggests the market is paying unusually little for the net assets.
- Goodwill and intangibles from acquisitions can inflate book value significantly — some analysts prefer tangible book value.
- Low P/B in technology or software companies is usually irrelevant: their value is in IP and people, not balance sheet assets.
Is EW P/B High or Low Right Now?
Edwards Lifesciences Corporation's P/B is currently 4.5, which is historically cheap relative to its 10-year historical range. The 10-year median P/B for EW is approximately 8.9. See all EW valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.